Member

Switch to:

Provider tip: use Magellan Rx website to submit preauth requests for IVIG, SCIG and Remicade products

01/29/2018

ConnectiCare has contracted with Magellan Rx Management (Magellan Rx) to manage the review of preauthorization requests for the following specialty drugs for both our commercial and Medicare Advantage plans:

  • Intravenous Immunoglobulin (IVIG)
  • Subcutaneous Immunoglobulin (SCIG)
  • Remicade® (infliximab)
  • All Remicade’s biosimilar products 

To help you submit preauthorization requests, Magellan Rx’s secure website at ih.MagellanRx.com (registration and log in required) is available 24 hours a day, seven days a week. The website will guide you through submitting the information needed for the review. Here are highlights of other features available through the Magellan Rx website.